• More than 2,000 people currently work in our Galway and Maple Grove plants on TAXUS system production;

• Each plant provides complete manufacturing capabilities, including bare-metal stent production, catheter production, stent coating, system assembly and analytical testing. This vertically integrated structure provides critical redundancy;

• Together, the two plants have the capacity to handle an estimated 85 percent worldwide market share with additional surge capacity.

This positive assessment of our preparedness is not only an internal view; our manufacturing systems and capacities have been recognized by respected independent sources as well. Our Maple Grove plant won Industry Week magazine’s Best Plant award, a recognition given to only ten manufacturing facilities from all industries in North America.